[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Venture Planning Group: Market Research Reports

VPGMarketResearch.com is a notable management consulting and research agency rendering high rate services to corporate executives and top decision makers. VPGMarketResearch.com conducts syndicated and custom research across the following industries:

  • Biotechnology
  • Chemicals
  • Food processing
  • Electronics
  • Healthcare
  • Pharmaceuticals


Close national and global links have been established with public-sector and financial bodies, governments, other research agencies, top executives and experts that extremely enriched VPG’s capabilities to provide extensive and relevant studies. This much contributed to the database creation that contains materials on a great number of markets, industrial sectors, companies, products, technologies, key market participants and management boards. For today more than 1,000 companies from 70 countries are in VPG’s client network. VPG market reports comprise essential knowledge including:

  • Market segmentation
  • Competitive landscape
  • Regulatory policies
  • Latest technology trends
  • Acquisition evaluations
  • Vendors’ analysis, etc.
Publications found: 56,184
Sort by:

2014 Analysis of Makhteshim-Agan

US$ 1,960.00

This strategic assessment of Makhteshim-Agan, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 24 pages

2014 Analysis of Monsanto

US$ 1,960.00

This strategic assessment of Monsanto, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 25 pages

2014 Analysis of Nufarm

US$ 1,960.00

This strategic assessment of Nufarm, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive ...

November 2013 33 pages

2014 Analysis of Akzo Nobel

US$ 1,960.00

This strategic assessment of Akzo Nobel, one of the world€™s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 45 pages

2014 Analysis of BASF in the Worldwide Paint and Coatings Market

US$ 1,960.00

This strategic assessment of BASF, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 58 pages

2014 Analysis of DuPont in the Worldwide Paint and Coatings Market

US$ 1,960.00

This strategic assessment of DuPont, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 44 pages

2014 Analysis of Kansai Paint

US$ 1,960.00

This strategic assessment of Kansai Paint, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 31 pages

2014 Analysis of Nippon Paint

US$ 1,960.00

This strategic assessment of Nippon Paint, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 36 pages

2014 Analysis of Sherwin-Williams

US$ 1,960.00

This strategic assessment of Sherwin-Williams, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group ...

November 2013 37 pages

2014 Analysis of Valspar

US$ 1,960.00

This strategic assessment of Valspar, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 30 pages

2014 Analysis of Henkel

US$ 1,960.00

This strategic assessment of Henkel, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 60 pages

2014 Analysis of RPM

US$ 1,960.00

This strategic assessment of RPM, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 31 pages

2014 Analysis of Bayer in the Worldwide Agrochemicals Market

US$ 1,960.00

This strategic assessment of Bayer, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive ...

November 2013 66 pages

2014 Analysis of Dow Chemical in the Worldwide Agrochemicals Market

US$ 1,960.00

This strategic assessment of Dow Chemical, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 59 pages

2014 Analysis of Syngenta

US$ 1,960.00

This strategic assessment of Syngenta, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...

November 2013 25 pages

2014 Analysis of FMC in the Worldwide Agrochemicals Market

US$ 1,960.00

This strategic assessment of FMC, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive ...

November 2013 40 pages

2014 Analysis of Firmenich

US$ 1,960.00

This strategic assessment of Firmenich, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...

November 2013 47 pages

2014 Analysis of Givaudan

US$ 1,960.00

This strategic assessment of Givaudan, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...

November 2013 50 pages

2014 Analysis of T. Hasegawa

US$ 1,960.00

This strategic assessment of T. Hasegawa, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...

November 2013 33 pages

2014 Analysis of IFF

US$ 1,960.00

This strategic assessment of IFF, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...

November 2013 65 pages

2014 Analysis of Mane

US$ 1,960.00

This strategic assessment of Mane, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...

November 2013 26 pages

2014 Analysis of Robertet

US$ 1,960.00

This strategic assessment of Robertet, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...

November 2013 21 pages

2014 Analysis of Sensient

US$ 1,960.00

This strategic assessment of Sensient, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...

November 2013 45 pages

2014 Analysis of Symrise

US$ 1,960.00

This strategic assessment of Symrise, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...

November 2013 70 pages

2014 Analysis of Takasago

US$ 1,960.00

This strategic assessment of Takasago, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...

November 2013 46 pages

2014 Tumor Markers Testing Market: Strategic Assessments of Major Suppliers

US$ 2,000.00

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative ...

November 2013 80 pages

2014 Microbiology Testing Market: Strategic Assessments of Leading Strategic Suppliers

US$ 1,480.00

This report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products in terms of their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains ...

November 2013 90 pages

2014 Coagulation Testing Market: Strategic Assessments of Major Suppliers

US$ 2,000.00

This report presents analyses of major current and emerging suppliers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 45 pages

November 2013 45 pages

2014 Hematology and Flow Cytometry Market: Strategic Assessments of Major Suppliers

US$ 1,480.00

This report presents strategic analyses of the major current and emerging suppliers in terms of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains 30 pages

November 2013 30 pages

2014 Analysis of Leading Diagnostic Imaging Suppliers' Strategic Directions

US$ 2,000.00

This new report from Venture Planning Group provides strategic directions of global diagnostic imaging companies. The report presents insightful strategic assessments, including: Business, new product development, and marketing strategies. Anticipated acquisitions, joint ventures, and divestitures. The ...

November 2013 41 pages

2014 Analysis of the Tumor Markers: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers

US$ 22,800.00

... : Biochemical Markers Oncogenes Growth Factors Hormones Colony Stimulating Factors Lymphokines Immunohistochemical Stains, and others. Analysis of major immunoassay analyzers used for tumor marker testing, including their operating characteristics, features and selling prices. Technology Review ...

November 2013 1200 pages

2014 Analysis of the Tumor Marker Testing Market in Europe: Market Segment Forecasts and Supplier Shares

US$ 15,760.00

... and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for ...

November 2013 820 pages

2014 Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs - Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures

US$ 3,160.00

... DataPack (test volumes, sales forecasts, supplier shares) $2,500. Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western ...

November 2013 277 pages

2014 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

US$ 3,120.00

Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test ...

November 2013 241 pages

2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures

US$ 5,520.00

Complete report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ...

November 2013 295 pages

2014 Analysis of the European Pap Smear/HPV Market

US$ 2,280.00

... . DataPack (test volumes, sales forecasts) $1,850. This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume ...

November 2013 235 pages

2014 Analysis of the US Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers, Physician Offices

US$ 1,800.00

... . During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself. This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and ...

November 2013 115 pages

2014 Analysis of the European Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers

US$ 3,080.00

... $2,500. The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8 ... and the analysis itself. This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries ...

November 2013 125 pages

2014 Analysis of the Emerging US Point-of-Care Testing Market: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 10,000.00

... Drugs of Abuse TDM Endocrine Function Tumor Markers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers. Current and Emerging Products Analysis of over 130 diagnostic procedures. Review of the leading POC chemistry, immunoassay ...

November 2013 1007 pages

2014 Analysis of the Diagnostic Testing Market US Ancillary Hospital Locations (ER, OR, ICU)

US$ 10,000.00

... 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ... instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies. ...

November 2013 973 pages

2014 Analysis of the Diagnostic Testing Market US Physician Offices and Group Practices: Supplier Shares and Sales Forecasts for Over 300 Tests

US$ 10,000.00

... Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers. Current and Emerging Products Analysis of over 130 diagnostic procedures. Review of leading chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, ...

November 2013 970 pages

2014 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers

US$ 4,400.00

... and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...

November 2013 795 pages

2014 Analysis of the US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major hematology and flow cytometry ...

November 2013 238 pages

2014 Analysis of the US Point-of-Care Clinical Chemistry Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major clinical chemistry reagent and ...

November 2013 373 pages

2014 Analysis of the US Point-of-Care Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 4,400.00

... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major coagulation reagent and instrument ...

November 2013 418 pages

2014 Analysis of the US PT and APTT Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers

US$ 2,320.00

... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers ...

November 2013 337 pages

2014 Analysis of the POC Lipid Testing Market in the US: Physician Offices, Emergency Rooms, Ambulatory Care Centers

US$ 2,320.00

... from Venture Planning Group contains 22 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, ... appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry ...

November 2013 305 pages

2014 Analysis of the US Drugs of Abuse Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Ambulatory Care Centers

US$ 2,000.00

... sales forecasts for drugs of abuse procedures by market segment: Physician Offices/Group Practices Emergency Rooms Ambulatory Care Centers Analysis of drugs of abuse procedures Competitive Assessments Assessments of major POC suppliers and emerging market entrants, including their sales, product ...

November 2013 165 pages

2014 Analysis of the US Home/Self Testing Market: Diabetes, Pregnancy, Ovulation, Occult Blood Business Challenges and Marketing Strategies for Suppliers

US$ 1,160.00

This new 175-page report from Venture Planning Group provides analysis of the major home/self testing market segments, including diabetes ( ... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of the home/self testing market segments, including diabetes ( ...

November 2013 175 pages

2014 Analysis of the French Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers

US$ 4,880.00

Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics ...

November 2013 585 pages

Filters

Search

Categories

3
6
274
2
181
177
55
791
640
521
450
393
313
216
877
245
242
201
65
33
17
17
15
14
10
8
7
5
4
3
2
2
2
1
1
2
5
1,403
45
603
33,695
43
8
15
2
1,389
1,108
252
1,228
146
97
1
69
3
53
631
6
932
21
6
1
253
3,934
324
1
644
585
228
219
202
97
69
35
17
15
813
27
344
88
11
1
1
591
20
108

Publishers

56,184

Regions

16
1
137
135
134
134
134
138
138
137
137
137
137
137
137
136
136
136
135
134
131
130
175
194
193
15
104
194
5
174
197
196
195
195
194
194
194
194
194
194
194
194
193
193
193
193
193
192
192
192
192
192
191
191
191
137
137
4
3
2
201
201
198
198
198
197
197
197
197
196
196
196
196
196
196
196
196
195
195
194
194
194
194
194
193
192
191
191
190
188
187
110
107
107
106
106
1,143
201
197
29,523
1,610
1,253
1,251
1,245
1,228
1,218
1,197
401
200

Price

Date

Pages

Offers